1. HOME
2. Research Insight
3. GE HealthCare (US) and Koninklijke Philips N.V. (Netherlands) are Leading Players in the Diagnostic Electrocardiograph (ECG) Market

The global Diagnostic Electrocardiogram (ECG) market is projected to reach USD 11.3 billion by 2028 from USD 8.1 billion in 2023, at a CAGR of 6.9% during the forecast period. Factors such as the increasing number of patients suffering from cardiovascular disease (CVD), increasing geriatric population globally, rising need for  early diagnosis of cardiac conditions, and technological advancements are  driving the growth of this market.

The Diagnostic ECG market is business is very competitive, with both established companies and newcomers competing for the same market share. As of 2022, the key players operating in the global diagnostic ECG market are GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Hill-Rom Holdings, Inc. (Baxter International Inc.) (US), Nihon Kohden Corporation (Japan), OSI Systems, Inc. (US), among others

To know about the assumptions considered for the study download the pdf brochure

GE HEALTHCARE (US)

GE HealthCare accounted for a major share of the Diagnostic ECG market in 2022. GE is a major player in this market due to its vast product portfolio. GE has a strong brand presence, well established  distribution partner network in more than 140 countries and provides expertise and services to customers worldwide. The company focuses on organic &  inorganic growth strategies to increase its market share. The company intends to partner with new players to strengthen its  existing business segments. For instance, in April 2022, GE Healthcare signed an agreement  with Deep Cardio to develop AI based ECG diagnostic technology and ECG data analysis program. Such developments enable the company to bring innovative diagnostic ECG products to its portfolio, which, in turn, will strengthen its global position in diagnostic ECG market

KONINKLIJKE PHILIPS N.V. (NETHERLANDS)

Koninklijke Philips N.V. focuses on strengthening its market position by enhancing its geographic footprint and focusing on adopting strategies such as collaboration & partnership. For instance, in 2021, the company acquired Biotelemetry to enhance its cardiac  care portfolio. Additionally, strongly emphasizes on investing in R&D and product launches to enhance its brand presence in the market and expand its customer base across globe.

Related Reports:

Diagnostic Electrocardiograph (ECG) Market by Product (Resting ECG, Stress, Mobile Cardiac Telemetry Device, Implantable Loop Recorder) and Service, Lead Type (12-lead, 6-lead, 5- lead), End User, and Region - Global Forecast to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]